login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
IRONWOOD PHARMACEUTICALS INC (IRWD) Stock News
USA
-
Nasdaq
- NASDAQ:IRWD -
US46333X1081
-
Common Stock
3.5
USD
-0.36 (-9.33%)
Last: 11/28/2025, 7:39:52 PM
3.48
USD
-0.02 (-0.57%)
After Hours:
11/28/2025, 7:39:52 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
IRWD Latest News, Press Relases and Analysis
All
Press Releases
19 days ago - By: Chartmill
- Mentions:
MPAA
SGRY
COGT
IMTE
...
Top movers analysis one hour before the close of the markets on 2025-11-10: top gainers and losers in today's session.
19 days ago - By: Chartmill
- Mentions:
FMFC
SGRY
COGT
IMTE
...
Top movers in Monday's session
2 days ago - By: Zacks Investment Research
- Mentions:
ABBV
PBYI
IRWD vs. PBYI: Which Small-Cap Biotech Stock Is the Better Pick?
8 days ago - By: Zacks Investment Research
- Mentions:
AZN
ABBV
Can Linzess Continue to Aid IRWD's Top Line After a Strong Q3?
16 days ago - By: Zacks Investment Research
- Mentions:
AZN
ABBV
IRWD Rises 110% in a Month: Should You Buy, Sell or Hold the Stock?
18 days ago - By: Zacks Investment Research
- Mentions:
AZN
ABBV
RLAY
IRWD Beats on Q3 Earnings & Revenues, Raises 2025 View, Stock Soars
19 days ago - By: Benzinga
- Mentions:
COGT
PBYI
AKBA
SGRY
...
12 Health Care Stocks Moving In Monday's Intraday Session
19 days ago - By: Chartmill
- Mentions:
FMFC
MOVE
SGRY
COGT
...
Let's uncover which stocks are experiencing notable gaps during today's session.
19 days ago - By: Benzinga
- Mentions:
LITE
VFF
EXK
PRTH
...
Pagaya Technologies Posts Upbeat Q3 Results, Joins Ironwood Pharmaceuticals, TreeHouse Foods And Other Big Stocks Moving Higher On Monday
19 days ago - By: Chartmill
- Mentions:
MOVE
RUBI
COGT
BKYI
...
Monday's pre-market session: top gainers and losers
19 days ago - By: Zacks Investment Research
- Mentions:
NTRB
Ironwood Pharmaceuticals (IRWD) Q3 Earnings and Revenues Surpass Estimates
19 days ago - By: Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance
23 days ago - By: Zacks Investment Research
- Mentions:
XNCR
Xencor (XNCR) Reports Q3 Loss, Misses Revenue Estimates
24 days ago - By: Stocktwits
- Mentions:
ABBV
GS
Ironwood Pharma Stock Soars After FDA Grants Approval For Irritable Bowel Syndrome Drug In Pediatric Patients
a month ago - By: Zacks Investment Research
- Mentions:
XERS
Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue?
3 months ago - By: Zacks Investment Research
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
4 months ago - By: Zacks Investment Research
- Mentions:
AZN
ABBV
EXAS
IRWD Stock Rises as Q2 Earnings & Revenues Trump Estimates
4 months ago - By: The Motley Fool
Ironwood (IRWD) Q2 EPS Jumps 600%
4 months ago - By: Zacks Investment Research
- Mentions:
PRPH
Ironwood Pharmaceuticals (IRWD) Beats Q2 Earnings and Revenue Estimates
4 months ago - By: Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance
6 months ago - By: Zacks Investment Research
- Mentions:
ZTS
Why Is Ironwood (IRWD) Down 18.4% Since Last Earnings Report?
7 months ago - By: Zacks Investment Research
- Mentions:
AZN
ABBV
ANIP
IRWD Stock Down 15% as Q1 Earnings & Revenues Miss Estimates
7 months ago - By: Stocktwits
- Mentions:
GS
WFC
Ironwood Pharma Stock Draws Retail Investor Ire With Big Q1 Miss And No Earnings Call
7 months ago - By: Yahoo Finance
- Mentions:
JNJ
HD
ABBV
TMO
...
Is Johnson & Johnson (JNJ) the Best Dow Stock?
7 months ago - By: Zacks Investment Research
- Mentions:
CRON
Ironwood Pharmaceuticals (IRWD) Reports Q1 Loss, Misses Revenue Estimates
7 months ago - By: Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
7 months ago - By: Yahoo Finance
- Mentions:
TTWO
MAT
SRAD
VVOS
...
Take-Two price target lowered to $236 from $240 at BMO Capital
Please enable JavaScript to continue using this application.